Citation Impact

Citing Papers

Hyperplasia and Carcinomas in Pten-Deficient Mice and Reduced PTEN Protein in Human Bladder Cancer Patients
2006 StandoutNobel
Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer
2015 StandoutNobel
FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis
2010 StandoutNobel
Overcoming tumor resistance to cisplatin by cationic lipid-assisted prodrug nanoparticles
2016
Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release
2010
A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours
2011
Engineering precision nanoparticles for drug delivery
2020 Standout
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags
2007 Standout
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
2011 Standout
Strategies for whole microbial genome sequencing and analysis
1997
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Preclinical and clinical studies of anticancer agent‐incorporating polymer micelles
2009
Mesoporous silica nanoparticles in biomedical applications
2012 StandoutNobel
Polymeric drug delivery of platinum-based anticancer agents
2008
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
2017 Standout
PROMIS — Prostate MR imaging study: A paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer
2015
Cancer drug resistance: an evolving paradigm
2013 Standout
Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?
2012
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Regulation of the p27Kip1 tumor suppressor by miR‐221 and miR‐222 promotes cancer cell proliferation
2007
Polymeric micelles for pH-responsive delivery of cisplatin
2014
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Prognostic relevance of the mTOR pathway in renal cell carcinoma
2007
Genomic organization of major sperm protein genes and pseudogenes in the nematode Caenorhabditis elegans
1988 StandoutNobel
Nanocarriers for delivery of platinum anticancer drugs
2013
Nano based drug delivery systems: recent developments and future prospects
2018 Standout
Micellar Nanocarriers: Pharmaceutical Perspectives
2006
First polymer “ruthenium-cyclopentadienyl” complex as potential anticancer agent
2013
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
2010 Standout
Effect of molecular weight of PGG–paclitaxel conjugates on in vitro and in vivo efficacy
2012
Targeting multidrug resistance in cancer
2006 Standout
MMAC1/PTEN inhibits cell growth and induces chemosensitivity to doxorubicin in human bladder cancer cells
2000
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
Nanovehicular Intracellular Delivery Systems
2008
Polymeric micelles for drug targeting
2007
A GWAS-identified susceptibility locus on chromosome 11q13.3 and its putative molecular target for prediction of postoperative prognosis of human renal cell carcinoma
2013
A novel multigene family may encode odorant receptors: A molecular basis for odor recognition
1991 StandoutNobel
Mind the gap: A survey of how cancer drug carriers are susceptible to the gap between research and practice
2013
Causes and consequences of microRNA dysregulation in cancer
2009 Standout
ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal.
2005
Platinum (IV)-coordinate polymers as intracellular reduction-responsive backbone-type conjugates for cancer drug delivery
2011
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
2010 Standout
Progress of drug-loaded polymeric micelles into clinical studies
2014
Tumor delivery of macromolecular drugs based on the EPR effect
2010 Standout
FOXO1 and TCF7L2 genes involved in metastasis and poor prognosis in clear cell renal cell carcinoma
2010
Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery
2006
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
2012 Standout
Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections
2020 Standout
Sustained and efficient porphyrin generation in vivo using dendrimer conjugates of 5-ALA for photodynamic therapy
2009
Radiosensitization of paclitaxel, etanidazole and paclitaxel+etanidazole nanoparticles on hypoxic human tumor cells in vitro
2007
Optimization of (1,2-diamino-cyclohexane)platinum(II)-loaded polymeric micelles directed to improved tumor targeting and enhanced antitumor activity
2007
Amphiphilic poly(l-amino acids) — New materials for drug delivery
2012
Delivery of platinum (II) drugs with bulky ligands in trans-geometry for overcoming cisplatin drug resistance
2018
Hypernatremic suppression of neutrophils
1997
Development of Multidrug-Resistance Convertors: Sense or Nonsense?
2000
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
The reversal of multidrug resistance: an update
2003
Poly (amino acid) micelle nanocarriers in preclinical and clinical studies
2008
Passive and Active Drug Targeting: Drug Delivery to Tumors as an Example
2009
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
THE EVOLUTION OF MULTIGENE FAMILIES: Human Haptoglobin Genes
1986 StandoutNobel
Novel SN-38–Incorporating Polymeric Micelles, NK012, Eradicate Vascular Endothelial Growth Factor–Secreting Bulky Tumors
2006
Nanoscale Metal–Organic Frameworks for Biomedical Imaging and Drug Delivery
2011 Standout
Haptoglobin: The Evolutionary Product of Duplication, Unequal Crossing Over, and Point Mutation
1982
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Phosphaplatins, next generation platinum antitumor agents: A paradigm shift in designing and defining molecular targets
2012
Mechanisms of Cisplatin Nephrotoxicity
2010 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Nanoparticles in Photodynamic Therapy
2015 Standout
The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials
2017 Standout
Black Pigment Gallstone Inspired Platinum‐Chelated Bilirubin Nanoparticles for Combined Photoacoustic Imaging and Photothermal Therapy of Cancers
2017
Black Pigment Gallstone Inspired Platinum‐Chelated Bilirubin Nanoparticles for Combined Photoacoustic Imaging and Photothermal Therapy of Cancers
2017
Clusters of Master Control Genes Regulate the Development of Higher Organisms
1992 StandoutNobel
Nanomedicine(s) under the Microscope
2011
Conjugate of Pt(IV)–Histone Deacetylase Inhibitor as a Prodrug for Cancer Chemotherapy
2012
Polymeric micelles for nano-scale drug delivery
2010
Correlation between Protein and mRNA Abundance in Yeast
1999 Standout
Prostate cancer detection with 3 T MRI: Comparison of diffusion‐weighted imaging and dynamic contrast‐enhanced MRI in combination with T2‐weighted imaging
2010
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Burn Wound Infections
2006 Standout
Polymorphisms in the human haptoglobin gene cluster: chromosomes with multiple haptoglobin-related (Hpr) genes.
1986 StandoutNobel
Core/Shell Nanoparticles: Classes, Properties, Synthesis Mechanisms, Characterization, and Applications
2011 Standout
Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials
2016
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation
2013
Analysis of nanoparticle delivery to tumours
2016 Standout
Chemodynamic Therapy: Tumour Microenvironment‐Mediated Fenton and Fenton‐like Reactions
2018 Standout
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies
2016
Nanoscaled Poly(l-glutamic acid)/Doxorubicin-Amphiphile Complex as pH-responsive Drug Delivery System for Effective Treatment of Nonsmall Cell Lung Cancer
2013
Clinical Translation of Nanomedicine
2015
Comparison of MR/Ultrasound Fusion–Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer
2015 Standout
Atomically Precise Clusters of Noble Metals: Emerging Link between Atoms and Nanoparticles
2017 Standout

Works of S Naito being referenced

Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats
2005
Development of novel reversal agents, imidazothiazole derivatives, targeting MDR1- and MRP-mediated multidrug resistance.
1998
NK105, a paclitaxel-incorporating micellar nanoparticle, is a more potent radiosensitising agent compared to free paclitaxel
2006
Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: Correlation with stepwise histopathology
2007
Suppression of Chemotactic Activity of Neutrophils in Hyperosmotic Conditions Comparable to the Renal Medulla: Partial Preservation by Phosphoenolpyruvate
1993
Non‐P‐glycoprotein‐mediated Atypical Multidrug Resistance in a Human Bladder Cancer Cell Line
1995
Increased expression of T‐plastin gene in cisplatin‐resistant human cancer cells: identification by mRNA differential display
1996
Type-dependent difference in the clearance rate of hemoglobin-haptoglobin complexes from the blood stream.
1967
Low expression of p27Kip1 is associated with tumor size and poor prognosis in patients with renal cell carcinoma
2002
Rankless by CCL
2026